Product Program year 2021 Source: CMS Open Payments

Nexplanon

Drug Womens Health

NDC 78206-145-01

Open in the dashboard

General payments

$2,445,548

4,319 payments

Research payments

$0

0 payments

Through program year 2021, $2,445,548 in general payments and $0 in research payments were reported against Nexplanon (Womens Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $2,445,548 4,319

Breakdown

Who paid General payments · program year 2021
  1. Organon LLC $2,445,548 4,319 payments
Top recipients General payments · program year 2021
  1. Edmund Kim Obstetrics & Gynecology · Lawrenceville, GA $57,420 2% · 88 payments
  2. Paula Jasionowski Nurse Practitioner, Obstetrics & Gynecology · Voorhees, NJ $55,735 2% · 93 payments
  3. Michael Green Obstetrics & Gynecology · Oxnard, CA $44,600 2% · 71 payments
  4. William Coleman Obstetrics & Gynecology · Greenville, SC $39,172 2% · 76 payments
  5. Linda New Physician Assistant · Lake Mary, FL $30,179 1% · 65 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Obstetrics & Gynecology $1,035,451 43% · 225 practitioners
  2. Family Medicine $373,310 15% · 289 practitioners
  3. Nurse Practitioner, Women's Health Nurse Practitioner $227,865 9% · 69 practitioners
  4. Advanced Practice Midwife $137,343 6% · 61 practitioners
  5. Nurse Practitioner, Obstetrics & Gynecology Nurse Practitioner $126,993 5% · 15 practitioners

The top 5 of 49 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $282,635 12% · 233 recipients
  2. Texas $197,378 8% · 207 recipients
  3. Pennsylvania $133,581 5% · 67 recipients
  4. Florida $132,875 5% · 55 recipients
  5. New Jersey $130,313 5% · 31 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

4,319 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record